News | Focused Ultrasound Therapy | April 12, 2017

Theraclion Reports Positive Long-Term Echopulse Results in Breast Fibroadenoma

Study results reveal mean volume reduction at 24 months; treatment is safe and well-tolerated by patients

April 12, 2017 — Theraclion announced results of a study evaluating the long-term assessment of breast fibroadenoma (benign tumor) volume reduction following treatment with the company’s Echopulse, a non-invasive treatment employing ultrasound-guided high-intensity focused ultrasound. The study, entitled “Long-term efficacy of ultrasound-guided high-intensity focused ultrasound (US-guided HIFU) treatment of breast fibroadenoma,” was published online in the March 2017 issue of the Journal of Therapeutic Ultrasound and is available online.

The study assessed a total of 20 female patients with 26 breast fibroadenomas (BFAs) before and for up to 24 months following echotherapy treatment with Echopulse. Nineteen BFAs received a single treatment and seven BFAs a second treatment six to nine months after the initial session. BFA volume was measured by ultrasound. Patient satisfaction on cosmetic results and symptom relief were surveyed and safety and tolerability was recorded. The study demonstrated consistent echotherapy results confirmed at 24 months:

  • Mean BFA volume was significantly reduced by 77.32 percent after a single procedure and by 90.47 percent after two procedures at 24 months follow up;
  • No cases of re-growth of treated lesions were observed during the 24 months follow-up;
  • Treatment was very well-tolerated regardless of whether one or two echotherapy sessions were performed. Side effects were mild and transient and resolved completely; no serious side effects were observed;
  • Of the 20 patients who completed a satisfaction survey, all 20 (100 percent) were completely or highly satisfied with the cosmetic results and 19 of 20 (95 percent) were completely or highly satisfied concerning symptom disappearance; and
  • Authors concluded that “US-guided HIFU represents a promising non-invasive method with sustainable FA volume reduction and patient’s tolerability. Although one treatment is highly efficient, the volume reduction can be increased with second treatment.”

Roussanka Kovatcheva, M.D., professor of endocrinology at the University Hospital of Endocrinology of Sofia, Bulgaria, and Principal Investigator said, “Our results show the long-term efficacy and safety of US-guided HIFU generated by Theraclion’s Echopulse in patients with breast fibroadenomas. US-guided HIFU is definitely an effective non-invasive alternative to surgery enabling more than 90 percent volume reduction without re-growth or serious adverse events.”

For more information: www.jtultrasound.biomedcentral.com

Related Content

Siemens Healthineers Introduces Mammomat Revelation Mammography System for Improved Biopsy Workflow
Technology | Mammography | December 11, 2017
Siemens Healthineers unveiled the new Mammomat Revelation premium mammography platform at the 2017 Radiological Society...
Breast Cancer Screening Performance Impacted by Mean Mammographic Compression Pressure
News | Mammography | December 08, 2017
Dutch researchers demonstrated a strong relationship between compression pressure in mammography and breast cancer...
Sponsored Content | Videos | Mammography | December 06, 2017
Martin Yaffe, Ph.D., FAAPM, senior scientist, physical sciences/imaging research, Sunnybrook Health Sciences Centre,
Ikonopedia and Konica Minolta Showcase Integrated Breast Imaging Workflow and Reporting at RSNA
News | Breast Imaging | December 05, 2017
Ikonopedia and Konica Minolta Healthcare Americas Inc. showcased integrated breast imaging workflow and reporting at...
Brain's Appetite Regulator Disrupted in Obese Teens
News | Neuro Imaging | December 05, 2017
December 5, 2017 — Advanced...
Sponsored Content | Videos | Breast Imaging | December 05, 2017
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, attending radiologis
Philips Azurion Platform Improves Clinical Workflow and Staff Experience Benefits
News | Angiography | December 04, 2017
Philips recently announced the results of a comprehensive, independent, two-year study demonstrating the clinical...
Numerous Studies Highlight Importance of Quantitative Breast Imaging Analysis at RSNA 2017
News | Breast Density | November 30, 2017
The importance of quantitative analysis in breast imaging was the focus of numerous abstracts accepted for presentation...
Hologic Receives FDA 510(k) Clearance of Quantra 2.2 Breast Density Assessment Software
Technology | Breast Density | November 28, 2017
Hologic Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its...
Eizo RadiForce RX560 Monitor Receives FDA 510(k) for Tomosynthesis and Digital Mammography
Technology | November 20, 2017
Eizo Corp. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for breast tomosynthesis...
Overlay Init